drug

elagolix

1 story · latest Nov 10, 2026

Follow elagolix. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jul 2018 · NDA210450
Brand: Orilissa

Relationships

Developed by AbbVie

Timeline

Atossa reports Q3 2026 results, outlines CVR tied to future priority review voucher

Nov 10Quarterly updateAtossa Therapeutics, Inc.endoxifen

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.